These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6903251)

  • 1. [Combined drug therapy of arterial circulation disorders].
    Grözinger KH
    Med Welt; 1980 Jul; 31(27):1015-8. PubMed ID: 6903251
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of peripheral circulatory disorders using BAY b 7979, demonstrated through Tc-99m muscular clearance].
    Nedjabat T; Ebinger H; Birtel FJ
    Med Welt; 1976 Aug; 27(34):1585-7. PubMed ID: 948260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effective therapy of chronic arterial circulatory disorders with Nico-Padutin forte (author's transl)].
    Vorberg G
    MMW Munch Med Wochenschr; 1976 Oct; 118(44):1429-32. PubMed ID: 825753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of peripheral arterial circulation disorders using Nico-Padutin forte].
    Hammer O
    ZFA (Stuttgart); 1976 Nov; 52(33):1740-3. PubMed ID: 795205
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the combined use of Nico-padutin forte and depot-Padutin in peripheral arterial occlusive disease].
    Hoffmann J
    Med Welt; 1982 Jul; 33(28):1034-7. PubMed ID: 6922390
    [No Abstract]   [Full Text] [Related]  

  • 6. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 8. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
    Blasi A; Licciardello M
    Clin Ter; 1966 Oct; 39(1):33-8. PubMed ID: 5998855
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic peripheral arterial circulation disorders. Experience with the management of chronic peripheral artertial circulation disorders using Complamine].
    Mund-Hoym WD
    ZFA (Stuttgart); 1978 Nov; 54(33):1726-32. PubMed ID: 568855
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conservative treatment of chronic arterial circulation disorders using a combination of adenosine, theophylline, and sodium nicotinate (ATN)].
    Meyer MP
    Z Haut Geschlechtskr; 1972 Jul; 47(13):565-9. PubMed ID: 4569523
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
    Feliciotti F; De Carolis G; Mariotti C; Mingolla F
    Ann Ital Chir; 1983; 55(5):493-7. PubMed ID: 6673630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihypertensive combination-therapy with inositol nicotinate in essential hypertension].
    Krämer KD; Ghabussi P; Hochrein H
    Med Welt; 1977 Jul; 28(27):1198-1201. PubMed ID: 329049
    [No Abstract]   [Full Text] [Related]  

  • 13. [Restless legs and crampi in the night. Double blind study with Circonyl in patients with defective peripheric arterial circulation (author's transl)].
    Hürlimann F
    Schweiz Rundsch Med Prax; 1974 Feb; 63(7):194-5. PubMed ID: 4605921
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
    Licata G; Pinto A; Parrinello G; Salli L; Indovina I
    Clin Ter; 1985 Mar; 112(6):503-13. PubMed ID: 4017475
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of physical therapy in peripheral arterial circulatory diseases (author's transl)].
    Krause D; Dittmar K
    Munch Med Wochenschr; 1973 Oct; 115(40):1742-4. PubMed ID: 4801041
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of cerebral vasculopathies with a new pharmacologic combination].
    Gazzi A
    Policlinico Med; 1966 Feb; 73(1):39-47. PubMed ID: 5941604
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role and place of prolonged intra-arterial infusion in the treatment of obliterating arterial diseases of the lower extremities].
    Belichenko IA; Kungurtsev VV; Dibirov MD
    Khirurgiia (Mosk); 1980 Mar; (3):48-51. PubMed ID: 7366097
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of the nicotinic ester of 7(2-hydroxyethyl)-theophylline on peripheral arteriopathies in the aged].
    Bandinelli G; De Mauro G; Provvedi D; Bellini PG; Rubegni M
    Cardiol Prat; 1973; 24(3):275-80. PubMed ID: 4779825
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effective and without side effects blood circulation therapy with Vascunicol].
    Schütz E
    Dtsch Med J; 1971 Mar; 22(6):180-3. PubMed ID: 4396738
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged therapy of insufficient cerebral circulation].
    Jansen W
    Med Monatsschr; 1970 Oct; 24(10):471-2. PubMed ID: 4394418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.